160 related articles for article (PubMed ID: 9731958)
21. Taurine: a potential novel addition to the anti-systemic sclerosis weaponry.
Fallahzadeh MK; Namazi MR; Gupta RC
Arch Med Res; 2010 Jan; 41(1):59-61. PubMed ID: 20430256
[TBL] [Abstract][Full Text] [Related]
22. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
23. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?
Abraham D
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v8-9. PubMed ID: 18784153
[TBL] [Abstract][Full Text] [Related]
24. Animal model of systemic sclerosis.
Yamamoto T
J Dermatol; 2010 Jan; 37(1):26-41. PubMed ID: 20175838
[TBL] [Abstract][Full Text] [Related]
25. Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma.
Shiwen X; Leask A; Abraham DJ; Fonseca C
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():19-26. PubMed ID: 19335743
[TBL] [Abstract][Full Text] [Related]
26. [Pathogenesis of scleroderma].
Marie I
Rev Prat; 2002 Nov; 52(17):1873-81. PubMed ID: 12532863
[TBL] [Abstract][Full Text] [Related]
27. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis.
Sakkas LI; Chikanza IC; Platsoucas CD
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):679-85. PubMed ID: 17133253
[TBL] [Abstract][Full Text] [Related]
29. Platelet contributions to the pathogenesis of systemic sclerosis.
Postlethwaite AE; Chiang TM
Curr Opin Rheumatol; 2007 Nov; 19(6):574-9. PubMed ID: 17917538
[TBL] [Abstract][Full Text] [Related]
30. Immunological basis of systemic sclerosis.
Zuber JP; Spertini F
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii23-5. PubMed ID: 16987826
[TBL] [Abstract][Full Text] [Related]
31. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
32. [Etiopathogenesis of progressive systemic sclerosis].
Markeljević J; Horvat Z
Lijec Vjesn; 1989; 111(1-2):43-6. PubMed ID: 2739500
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
34. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
Fineschi S; Cozzi F; Burger D; Dayer JM; Meroni PL; Chizzolini C
Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
[TBL] [Abstract][Full Text] [Related]
35. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?
Yamamoto T
Arch Dermatol Res; 2006 Feb; 297(8):333-44. PubMed ID: 16402183
[TBL] [Abstract][Full Text] [Related]
36. Increased bleomycin-induced skin fibrosis in mice lacking the Th1-specific transcription factor T-bet.
Lakos G; Melichian D; Wu M; Varga J
Pathobiology; 2006; 73(5):224-37. PubMed ID: 17314493
[TBL] [Abstract][Full Text] [Related]
37. Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective.
Yamamoto T; Nishioka K
Exp Dermatol; 2005 Feb; 14(2):81-95. PubMed ID: 15679577
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
Hasegawa M; Fujimoto M; Takehara K; Sato S
J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
[TBL] [Abstract][Full Text] [Related]
39. [Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 1: pathogenesis].
Zuber JP; Chizzolini C; Leimgruber A; Bart PA; Spertini F
Rev Med Suisse; 2006 Apr; 2(62):1052-7. PubMed ID: 16711150
[TBL] [Abstract][Full Text] [Related]
40. Cytokine modulation by endothelin-1 and possible therapeutic implications in systemic sclerosis.
Giordano N; Papakostas P; Pecetti G; Nuti R
J Biol Regul Homeost Agents; 2011; 25(4):487-92. PubMed ID: 22217982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
